Avedro Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avedro Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3350
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-linking; IROC Innocross for ocular pathology; and riboflavin formulations for various cross-linking needs. It also manufactures capital equipment and single dose pharmaceuticals. Averdro’s products are used in the treatment of eye conditions such as keratoconus and corneal ectasia. The company markets its products through a network of ophthalmic medical device distributors and sales representatives for healthcare markets across the US. Averdro is headquartered in Waltham, Massachusetts, the US.

Avedro Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avedro Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avedro Inc, Medical Devices Deals, 2012 to YTD 2018 9
Avedro Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avedro Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Avedro Raises USD25 Million in Venture Financing 11
Avedro Raises USD42 Million in Equity and Debt Financing 13
Avedro Raises USD12 Million in Venture Financing 14
Avedro Raises USD32 Million in Equity Financing Round 15
Partnerships 16
Avedro Enters Into Option Agreement With Cleveland Clinic To License Intellectual Property Assets 16
Avedro Inc – Key Competitors 17
Avedro Inc – Key Employees 18
Avedro Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Jul 31, 2018: Thomas W. Burns, CEO of Glaukos, Joins Avedro’s Board of Directors 20
Apr 10, 2018: Avedro Names James Schuermann Chief Business Officer 21
Jul 18, 2017: Donald J. Zurbay Joins Avedro’s Board of Directors 22
Jun 20, 2017: Avedro Names Thomas E. Griffin Chief Financial Officer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Avedro Inc, Pharmaceuticals & Healthcare, Key Facts 2
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avedro Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avedro Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Avedro Inc, Medical Devices Deals, 2012 to YTD 2018 9
Avedro Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avedro Raises USD25 Million in Venture Financing 11
Avedro Raises USD42 Million in Equity and Debt Financing 13
Avedro Raises USD12 Million in Venture Financing 14
Avedro Raises USD32 Million in Equity Financing Round 15
Avedro Enters Into Option Agreement With Cleveland Clinic To License Intellectual Property Assets 16
Avedro Inc, Key Competitors 17
Avedro Inc, Key Employees 18
Avedro Inc, Other Locations 19

List of Figures
Avedro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avedro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avedro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avedro Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Avedro Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GenKyoTex SA (GKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary GenKyoTex SA (GenKyoTex), formerly Genticel SA, is a biopharmaceutical company that develops NOX therapies. The company develops targeted NOX inhibitors and molecule therapeutics that inhibit the NOX family of enzymes. GenKyoTex’s lead product candidate, GKT831, a selective NOX1/4 inhibitor, …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GQ Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary GQ Life Sciences Inc (GQ Life Sciences), formerly GenomeQuest Inc, a subsidiary of Aptean Inc, is a life science information and search company that offers genomic software to search patents for biological sequences. The company provides lifequest, a patent search tool that provides a soluti …
  • RTI Surgical Inc (RTIX)-医療機器分野:企業M&A・提携分析
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • First Solar Inc (FSLR):電力:M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務分析
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • Cipla Ltd (CIPLA):医療機器:M&Aディール及び事業提携情報
    Summary Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetologi …
  • WPG Resources Ltd (WPG):企業の財務・戦略的SWOT分析
    Summary WPG Resources Ltd (WPG) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, nickel, base metals, iron ore, and coal properties in South Australia. Its projects comprise Tunkillia gold project, Tarcoola gold …
  • CooperVision Inc:製品パイプライン分析
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Trammo Inc.:企業の戦略・SWOT・財務情報
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Berkshire Hathaway Energy Co:電力:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • Greif, Inc.:企業の戦略・SWOT・財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Singulex Inc-医療機器分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Rizzani De Eccher S.P.A.
    Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Celator Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • GSS Infotech Limited (GSS):企業の財務・戦略的SWOT分析
    GSS Infotech Limited (GSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆